blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3360571

EP3360571 - ANTIBODIES BINDING TO AN INTRACELLULAR PRL-1 OR PRL-3 POLYPEPTIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.10.2021
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  13.11.2020
FormerGrant of patent is intended
Status updated on  14.07.2020
FormerRequest for examination was made
Status updated on  13.07.2018
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Agency For Science, Technology And Research (A*star)
1 Fusionopolis Way 20-10 Connexis
Singapore 138632 / SG
[2018/33]
Inventor(s)01 / ZENG, Qi
61 Biopolis Drive
Proteos
138632 Singapore / SG
 [2018/33]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2020/51]
Former [2018/33]Salisbury, Frances, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date18160806.803.05.2008
[2018/33]
Priority number, dateUS20070924201P03.05.2007         Original published format: US 924201 P
US20080064229P22.02.2008         Original published format: US 64229 P
[2018/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3360571
Date:15.08.2018
Language:EN
[2018/33]
Type: B1 Patent specification 
No.:EP3360571
Date:16.12.2020
Language:EN
[2020/51]
Search report(s)(Supplementary) European search report - dispatched on:EP09.05.2018
ClassificationIPC:A61K39/395, A61P35/00, C07K16/18, C07K16/30, C07K16/40
[2018/33]
CPC:
C07K16/40 (EP,CN,GB,US); A61K39/395 (GB); A61K39/3955 (GB);
A61K39/39558 (US); A61P35/00 (EP); A61P35/04 (EP);
C07K16/18 (EP,CN,GB,US); C07K16/30 (EP,US); C12N15/52 (GB);
C12N5/0693 (GB); G01N33/5005 (GB); G01N33/53 (GB);
G01N33/57496 (EP,US); A61K2039/505 (EP,CN,US); C07K2317/24 (EP,CN,US);
C07K2317/34 (EP,CN,US); C07K2317/56 (CN,US); C07K2317/73 (EP,CN,US);
C07K2317/76 (EP,CN,US); C07K2317/77 (EP,CN,US); G01N2333/916 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2020/45]
Former [2018/33]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:AN EIN INTRAZELLULARES PRL-1- ODER PRL-3-POLYPEPTID BINDENDE ANTIKÖRPER[2018/33]
English:ANTIBODIES BINDING TO AN INTRACELLULAR PRL-1 OR PRL-3 POLYPEPTIDE[2018/33]
French:ANTICORPS À LIAISON SUR UN POLYPEPTIDE PRL-1 OU PRL-3 INTRACELLULAIRE[2018/33]
Examination procedure08.03.2018Date on which the examining division has become responsible
21.03.2018Examination requested  [2018/33]
28.03.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
15.07.2020Communication of intention to grant the patent
05.11.2020Fee for grant paid
05.11.2020Fee for publishing/printing paid
05.11.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP08754007.6  / EP2150276
EP12159080.6  / EP2529754
Opposition(s)17.09.2021No opposition filed within time limit [2021/47]
Request for further processing for:The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
29.05.2019Request for further processing filed
Fees paidRenewal fee
21.03.2018Renewal fee patent year 03
21.03.2018Renewal fee patent year 04
21.03.2018Renewal fee patent year 05
21.03.2018Renewal fee patent year 06
21.03.2018Renewal fee patent year 07
21.03.2018Renewal fee patent year 08
21.03.2018Renewal fee patent year 09
21.03.2018Renewal fee patent year 10
21.03.2018Renewal fee patent year 11
22.05.2019Renewal fee patent year 12
29.05.2020Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.05.2008
CY16.12.2020
CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
MT16.12.2020
PL16.12.2020
RO16.12.2020
SI16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
[2024/42]
Former [2023/33]HU03.05.2008
CY16.12.2020
CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
PL16.12.2020
RO16.12.2020
SI16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2023/24]CY16.12.2020
CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
PL16.12.2020
RO16.12.2020
SI16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2022/13]CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
PL16.12.2020
RO16.12.2020
SI16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2022/07]CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
MC16.12.2020
PL16.12.2020
RO16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2021/42]CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
PL16.12.2020
RO16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
IS16.04.2021
PT16.04.2021
Former [2021/39]CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
PL16.12.2020
RO16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/36]CZ16.12.2020
EE16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
RO16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/35]CZ16.12.2020
HR16.12.2020
LT16.12.2020
LV16.12.2020
RO16.12.2020
SK16.12.2020
BG16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/33]HR16.12.2020
LT16.12.2020
LV16.12.2020
BG16.03.2021
GR17.03.2021
PT16.04.2021
Former [2021/28]HR16.12.2020
LV16.12.2020
BG16.03.2021
GR17.03.2021
Former [2021/23]LV16.12.2020
BG16.03.2021
GR17.03.2021
Documents cited:Search[A]US2005287644  (CHIU YI-FANG [TW], et al);
 [A]WO2006091326  (ATTOGEN INC [US], et al);
by applicantUS3791932
 US3839153
 US3850752
 US3850578
 US3853987
 US3867517
 US3879262
 US3901654
 US3935074
 US3984533
 US3996345
 US4034074
 US4098876
 EP0088695
 US4683195
 US4683202
 WO8807378
 US4879219
 US5011771
 WO9111201
 US5281521
 WO9521927
 WO9530018
 US6100090
 WO1995GB00322
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.